SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-535541
Filing Date
2016-04-08
Accepted
2016-04-08 16:25:12
Documents
19
Period of Report
2016-05-19
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d161865ddef14a.htm DEF 14A 944874
2 GRAPHIC g161865g02l38.jpg GRAPHIC 31089
3 GRAPHIC g161865g03s59.jpg GRAPHIC 60319
4 GRAPHIC g161865g10x41.jpg GRAPHIC 74529
5 GRAPHIC g161865g11p31.jpg GRAPHIC 30868
6 GRAPHIC g161865g14p00.jpg GRAPHIC 30622
7 GRAPHIC g161865g24f36.jpg GRAPHIC 61166
8 GRAPHIC g161865g25k91.jpg GRAPHIC 31631
9 GRAPHIC g161865g36x62.jpg GRAPHIC 29015
10 GRAPHIC g161865g41y22.jpg GRAPHIC 33552
11 GRAPHIC g161865g48w41.jpg GRAPHIC 31398
12 GRAPHIC g161865g58l89.jpg GRAPHIC 15652
13 GRAPHIC g161865g66u25.jpg GRAPHIC 31467
14 GRAPHIC g161865g71u18.jpg GRAPHIC 6213
15 GRAPHIC g161865g77k86.jpg GRAPHIC 32896
16 GRAPHIC g161865g86h57.jpg GRAPHIC 31818
17 GRAPHIC g161865g86n67.jpg GRAPHIC 60789
18 GRAPHIC g161865g98b67.jpg GRAPHIC 41297
19 GRAPHIC g161865g99q88.jpg GRAPHIC 31229
  Complete submission text file 0001193125-16-535541.txt   1863978
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33137 | Film No.: 161562952
SIC: 2834 Pharmaceutical Preparations